Visualization of drug target interactions in the contexts of pathways and networks with reactomefiviz

Aurora S. Blucher, Shannon McWeeney, Lincoln Stein, Guanming Wu

Research output: Contribution to journalReview article

Abstract

The precision medicine paradigm is centered on therapies targeted to particular molecular entities that will elicit an anticipated and controlled therapeutic response. However, genetic alterations in the drug targets themselves or in genes whose products interact with the targets can affect how well a drug actually works for an individual patient. To better understand the effects of targeted therapies in patients, we need software tools capable of simultaneously visualizing patient-specific variations and drug targets in their biological context. This context can be provided using pathways, which are process-oriented representations of biological reactions, or biological networks, which represent pathway-spanning interactions among genes, proteins, and other biological entities. To address this need, we have recently enhanced the Reactome Cytoscape app, ReactomeFIViz, to assist researchers in visualizing and modeling drug and target interactions. ReactomeFIViz integrates drug-target interaction information with high quality manually curated pathways and a genome-wide human functional interaction network. Both the pathways and the functional interaction network are provided by Reactome, the most comprehensive open source biological pathway knowledgebase. We describe several examples demonstrating the application of these new features to the visualization of drugs in the contexts of pathways and networks. Complementing previous features in ReactomeFIViz, these new features enable researchers to ask focused questions about targeted therapies, such as drug sensitivity for patients with different mutation profiles, using a pathway or network perspective.

Original languageEnglish (US)
Article number908
JournalF1000Research
Volume8
DOIs
StatePublished - Jan 1 2019

Fingerprint

Drug Interactions
Visualization
Pharmaceutical Preparations
Research Personnel
Precision Medicine
Knowledge Bases
Genes
Human Genome
Therapeutics
Software
Application programs
Medicine
Mutation
Proteins

Keywords

  • Biological pathway
  • Boolean network
  • Constrained fuzzy logic modeling
  • Drug interaction visualization
  • Functional interaction network
  • Reactome
  • Systems pharmacology
  • Targeted therapy

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Visualization of drug target interactions in the contexts of pathways and networks with reactomefiviz. / Blucher, Aurora S.; McWeeney, Shannon; Stein, Lincoln; Wu, Guanming.

In: F1000Research, Vol. 8, 908, 01.01.2019.

Research output: Contribution to journalReview article

@article{cce306ba08ae4d0cab90079360daf072,
title = "Visualization of drug target interactions in the contexts of pathways and networks with reactomefiviz",
abstract = "The precision medicine paradigm is centered on therapies targeted to particular molecular entities that will elicit an anticipated and controlled therapeutic response. However, genetic alterations in the drug targets themselves or in genes whose products interact with the targets can affect how well a drug actually works for an individual patient. To better understand the effects of targeted therapies in patients, we need software tools capable of simultaneously visualizing patient-specific variations and drug targets in their biological context. This context can be provided using pathways, which are process-oriented representations of biological reactions, or biological networks, which represent pathway-spanning interactions among genes, proteins, and other biological entities. To address this need, we have recently enhanced the Reactome Cytoscape app, ReactomeFIViz, to assist researchers in visualizing and modeling drug and target interactions. ReactomeFIViz integrates drug-target interaction information with high quality manually curated pathways and a genome-wide human functional interaction network. Both the pathways and the functional interaction network are provided by Reactome, the most comprehensive open source biological pathway knowledgebase. We describe several examples demonstrating the application of these new features to the visualization of drugs in the contexts of pathways and networks. Complementing previous features in ReactomeFIViz, these new features enable researchers to ask focused questions about targeted therapies, such as drug sensitivity for patients with different mutation profiles, using a pathway or network perspective.",
keywords = "Biological pathway, Boolean network, Constrained fuzzy logic modeling, Drug interaction visualization, Functional interaction network, Reactome, Systems pharmacology, Targeted therapy",
author = "Blucher, {Aurora S.} and Shannon McWeeney and Lincoln Stein and Guanming Wu",
year = "2019",
month = "1",
day = "1",
doi = "10.12688/f1000research.19592.1",
language = "English (US)",
volume = "8",
journal = "F1000Research",
issn = "2046-1402",
publisher = "F1000 Research Ltd.",

}

TY - JOUR

T1 - Visualization of drug target interactions in the contexts of pathways and networks with reactomefiviz

AU - Blucher, Aurora S.

AU - McWeeney, Shannon

AU - Stein, Lincoln

AU - Wu, Guanming

PY - 2019/1/1

Y1 - 2019/1/1

N2 - The precision medicine paradigm is centered on therapies targeted to particular molecular entities that will elicit an anticipated and controlled therapeutic response. However, genetic alterations in the drug targets themselves or in genes whose products interact with the targets can affect how well a drug actually works for an individual patient. To better understand the effects of targeted therapies in patients, we need software tools capable of simultaneously visualizing patient-specific variations and drug targets in their biological context. This context can be provided using pathways, which are process-oriented representations of biological reactions, or biological networks, which represent pathway-spanning interactions among genes, proteins, and other biological entities. To address this need, we have recently enhanced the Reactome Cytoscape app, ReactomeFIViz, to assist researchers in visualizing and modeling drug and target interactions. ReactomeFIViz integrates drug-target interaction information with high quality manually curated pathways and a genome-wide human functional interaction network. Both the pathways and the functional interaction network are provided by Reactome, the most comprehensive open source biological pathway knowledgebase. We describe several examples demonstrating the application of these new features to the visualization of drugs in the contexts of pathways and networks. Complementing previous features in ReactomeFIViz, these new features enable researchers to ask focused questions about targeted therapies, such as drug sensitivity for patients with different mutation profiles, using a pathway or network perspective.

AB - The precision medicine paradigm is centered on therapies targeted to particular molecular entities that will elicit an anticipated and controlled therapeutic response. However, genetic alterations in the drug targets themselves or in genes whose products interact with the targets can affect how well a drug actually works for an individual patient. To better understand the effects of targeted therapies in patients, we need software tools capable of simultaneously visualizing patient-specific variations and drug targets in their biological context. This context can be provided using pathways, which are process-oriented representations of biological reactions, or biological networks, which represent pathway-spanning interactions among genes, proteins, and other biological entities. To address this need, we have recently enhanced the Reactome Cytoscape app, ReactomeFIViz, to assist researchers in visualizing and modeling drug and target interactions. ReactomeFIViz integrates drug-target interaction information with high quality manually curated pathways and a genome-wide human functional interaction network. Both the pathways and the functional interaction network are provided by Reactome, the most comprehensive open source biological pathway knowledgebase. We describe several examples demonstrating the application of these new features to the visualization of drugs in the contexts of pathways and networks. Complementing previous features in ReactomeFIViz, these new features enable researchers to ask focused questions about targeted therapies, such as drug sensitivity for patients with different mutation profiles, using a pathway or network perspective.

KW - Biological pathway

KW - Boolean network

KW - Constrained fuzzy logic modeling

KW - Drug interaction visualization

KW - Functional interaction network

KW - Reactome

KW - Systems pharmacology

KW - Targeted therapy

UR - http://www.scopus.com/inward/record.url?scp=85070576363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070576363&partnerID=8YFLogxK

U2 - 10.12688/f1000research.19592.1

DO - 10.12688/f1000research.19592.1

M3 - Review article

VL - 8

JO - F1000Research

JF - F1000Research

SN - 2046-1402

M1 - 908

ER -